InMed Pharmaceuticals (INM) Accumulated Expenses (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Accumulated Expenses of $373540.0 for Q1 2026, down 19.61% year-over-year from $464665.0 in Q1 2025, and down 0.83% quarter-over-quarter from $376656.0 in Q4 2025.
InMed Pharmaceuticals (INM) Accumulated Expenses (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $373540.0 for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 19.61% year-over-year to $373540.0; the TTM figure through Mar 2026 stood at $373540.0 (down 19.61% YoY), while the FY2025 annual figure was $417927.0, down 14.41% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $373540.0, down from $376656.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $488278.0 in Q2 2024, with the low at $54629.0 in Q1 2024.
- The 5-year median for Accumulated Expenses is $308396.0 (2023), against an average of $276138.4.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses plunged 69.41% in 2024, then jumped 750.58% in 2025.
- InMed Pharmaceuticals' Accumulated Expenses stood at $139120.0 in 2022, then declined by 26.84% to $101775.0 in 2023, then soared by 231.35% to $337236.0 in 2024, then gained by 11.69% to $376656.0 in 2025, then fell by 0.83% to $373540.0 in 2026.
- Business Quant data shows INM's Accumulated Expenses at $373540.0 in Q1 2026, $376656.0 in Q4 2025, and $274250.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | InMed Pharmaceuticals | 6.03 Mn | 790,206.45 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 373,540.00 |
| Dec 31, 2025 | 376,656.00 |
| Sep 30, 2025 | 274,250.00 |
| Jun 30, 2025 | 417,927.00 |
| Mar 31, 2025 | 464,665.00 |
| Dec 31, 2024 | 337,236.00 |
| Sep 30, 2024 | 85,521.00 |
| Jun 30, 2024 | 488,278.00 |
| Mar 31, 2024 | 54,629.00 |
| Dec 31, 2023 | 101,775.00 |
| Sep 30, 2023 | 279,556.00 |
| Jun 30, 2023 | 357,664.00 |
| Jun 30, 2022 | 139,120.00 |
| Mar 31, 2022 | 115,120.00 |
| Dec 31, 2021 | 382,114.00 |
| Sep 30, 2021 | 137,552.00 |
| Jun 30, 2021 | 169,641.00 |
| Mar 31, 2021 | 65,569.00 |
| Dec 31, 2020 | 364,841.00 |
| Sep 30, 2020 | 497,999.00 |